Science & Technology

Manufacturing and Analytical Validation of the Microfluidic Impedance Red Cell Assay (MIRCA) for Commercial Viability

Department of Health and Human Services — National Institutes of Health

Opportunity #: 1R42HL182546-01

Award Ceiling

$312K

Award Floor

$312K

Close Date

Jun 30, 2028

838 days left

Total Funding

$312K

Expected Awards

Posted Date

Sep 15, 2025

Cost Sharing Required

Grants.gov ID

sbir-1R42HL182546-01

Description

STTR Phase Phase I award: "Manufacturing and Analytical Validation of the Microfluidic Impedance Red Cell Assay (MIRCA) for Commercial Viability" awarded to BIOCHIP LABS, INC. in Cleveland, Ohio. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $312,371. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses, HUBZone businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.